Truly Technologies Analysis
What is Truly Technologies?
Truly Technologies develops biospecimen processing solutions using osmotic pressure across semipermeable membranes to concentrate and purify biomolecules. The technology isolates target biomolecules with high yield and purity by leveraging water diffusion through membrane pores. It operates without power, requires only three simple steps, and scales from microliters to liters. The platform is designed for in vitro diagnostics, therapeutic processing, and laboratory research.
Location
Seattle, United States
Employees
1-10
Founded
2021
Product Features & Capabilities
- Osmotic membrane-based biomolecule concentration and purification
- High-yield, high-purity isolation of biomolecules
- Power-free operation in three simple steps
- Scalable from microliter to liter sample volumes
- Customizable device form factor for specific use cases
Use Cases
Concentrate diagnostic biomarkers from low-concentration samples; Purify therapeutic nanoparticles for drug delivery; Isolate proteins from complex cell mixtures; Prepare samples for downstream assays in research labs; Enable rapid testing in point-of-care in vitro diagnostics
Other Considerations
University of Washington spinout; Backed by academic research and innovation ecosystem; Recognized by industry leaders for diagnostic applications; Partnerships with diagnostics assay development companies; No specific customer metrics or funding details provided
See something that needs updating? Suggest edits to this profile.